Cargando…
Minimally-Myelosuppressive Asparaginase-Containing Induction Regimen for Treatment of a Jehovah’s Witness with mutant IDH1/NPM1/NRAS Acute Myeloid Leukemia
Treatment of patients with acute myeloid leukemia (AML) who do not wish to accept blood product transfusion, including Jehovah’s Witnesses, is extremely challenging. The use of conventional chemotherapy for induction of complete remission (CR) results in profound anemia and thrombocytopenia requirin...
Autores principales: | Emadi, Ashkan, Bade, Najeebah A., Stevenson, Brandi, Singh, Zeba |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4812376/ https://www.ncbi.nlm.nih.gov/pubmed/27064021 http://dx.doi.org/10.3390/ph9010012 |
Ejemplares similares
-
Anesthetic management of Jehovah's Witness patients.
por: Kim, W. O.
Publicado: (1991) -
Surgery in Jehovah's Witnesses – our experience
por: Trzciński, Radzisław, et al.
Publicado: (2015) -
Evans Syndrome in a Jehovah’s Witness
por: Leonhardt, Lex P, et al.
Publicado: (2021) -
Successful transfusion-free pancreatectomy in Jehovah's Witness patients
por: Lee, Jong Oh, et al.
Publicado: (2016) -
Blood Transfusion in Children: The Refusal of Jehovah’s Witness Parents’
por: Conti, Adelaide, et al.
Publicado: (2018)